SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Li-Ying Shi, Zhe Han, Xiao-Xia Li, Mei Li, Han Han, Jun Chen, Sitao Zang, Inactivated Sendai Virus Strain Tianjin Induces Apoptosis in Breast Cancer MCF-7 Cells by Promoting Caspase Activation and Fas/FasL Expression, Cancer Biotherapy & Radiopharmaceuticals, 2015, 30, 1, 33

    CrossRef

  2. 2
    Han-Foon Neo, R. Devinaga, David Yoon Kin Tong, Chuan-Chin Teo, Tourists’ Satisfaction on the Use of Biometrics Technology: A Conceptual Framework, Journal of Economics, Business and Management, 2015, 3, 1, 98

    CrossRef

  3. 3
    Jun Chen, Han Han, Min Chen, Xiao-Zhu Xu, Bin Wang, Li-Ying Shi, Inactivated Sendai Virus Strain Tianjin Induces Apoptosis in Human Breast Cancer MDA-MB-231 Cells, Asian Pacific Journal of Cancer Prevention, 2014, 15, 12, 5023

    CrossRef

  4. 4
    Quan Zhang, Xiaoshuang Xu, Yan Yuan, Xiaocheng Gong, Zedong Chen, Xiangming Xu, IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus, International Journal of Cancer, 2014, 134, 1
  5. 5
    Motonari Nomura, Takashi Shimbo, Yasuhide Miyamoto, Masahiro Fukuzawa, Yasufumi Kaneda, 13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma, Cancer Science, 2013, 104, 2
  6. 6
    Yuki Takehara, Takahiro Satoh, Aya Nishizawa, Kazumi Saeki, Masataka Nakamura, Mikio Masuzawa, Yasufumi Kaneda, Ichiro Katayama, Hiroo Yokozeki, Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma, Clinical Immunology, 2013, 149, 1, 1

    CrossRef

  7. 7
    Subbiah Elankumaran, Genetically engineered Newcastle disease virus for prostate cancer: a magic bullet or a misfit, Expert Review of Anticancer Therapy, 2013, 13, 7, 769

    CrossRef

  8. 8
    Liying Shi, Jun Chen, Qiping Zhong, Mei Li, Peng Geng, Jianmin He, Zhe Han, Mingwei Sheng, Hua Tang, Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis, Journal of Translational Medicine, 2013, 11, 1, 205

    CrossRef

  9. 9
    Kotaro Saga, Yasufumi Kaneda, Virosome Presents Multimodel Cancer Therapy without Viral Replication, BioMed Research International, 2013, 2013, 1

    CrossRef

  10. 10
    Yasufumi Kaneda, Virosome: A novel vector to enable multi-modal strategies for cancer therapy, Advanced Drug Delivery Reviews, 2012, 64, 8, 730

    CrossRef

  11. 11
    Koji Hatano, Yasuhide Miyamoto, Norio Nonomura, Yasufumi Kaneda, Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells, International Journal of Cancer, 2011, 129, 8
  12. 12
    Masahide Matsuda, Keisuke Nimura, Takashi Shimbo, Toshimitsu Hamasaki, Tetsuya Yamamoto, Akira Matsumura, Yasufumi Kaneda, Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma, Journal of Neuro-Oncology, 2011, 103, 1, 19

    CrossRef

  13. 13
    Yasufumi Kaneda, A non-replicating oncolytic vector as a novel therapeutic tool against cancer, BMB Reports, 2010, 43, 12, 773

    CrossRef

  14. You have free access to this content14
    Hiroshi Fukuhara, Yukio Homma, Tomoki Todo, Oncolytic virus therapy for prostate cancer, International Journal of Urology, 2010, 17, 1
  15. 15
    Masahiko Tanaka, Takashi Shimbo, Yasushi Kikuchi, Masahide Matsuda, Yasufumi Kaneda, Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon, International Journal of Cancer, 2010, 126, 8
  16. 16
    Yasufumi Kaneda, Therapeutic strategies for controlling metastasis and recurrence of cancers, Drug Delivery System, 2010, 25, 2, 94

    CrossRef

  17. 17
    M Matsuda, T Yamamoto, A Matsumura, Y Kaneda, Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope, Gene Therapy, 2009, 16, 12, 1465

    CrossRef

  18. 18
    Sarah Payton, Prostate Cancer: Tumor cells driven to suicide by inactivated virus, Nature Reviews Urology, 2009, 6, 7, 346

    CrossRef

  19. 19
    Atsushi Kitani, Stefan Fichtner-Feigl, Efficient In Vivo Delivery of Plasmids and Oligonucleotides Using Hemagglutinating Virus of Japan Envelope (HVJ-E) Vector in Immunological Disease Models, Current Protocols in Immunology,